Angiopoietin-like 3: An important protein in regulating lipoprotein levels-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Angiopoietin-like 3: An important protein in regulating lipoprotein levels

Published:2023-05 Issue:3 Volume:37 Page:101688
ISSN:1521-690X
Container-title:Best Practice & Research Clinical Endocrinology & Metabolism
language:en
Short-container-title:Best Practice & Research Clinical Endocrinology & Metabolism

Author:

Burks Kendall H.,Basu Debapriya,Goldberg Ira J.,Stitziel Nathan O.

Funder

National Lipid Association

National Institutes of Health

American Heart Association

Foundation for Barnes-Jewish Hospital

Neotropical Ornithological Society

National Ocean Service

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference65 articles.

1. Genetic heterogeneity in familial hypobetalipoproteinemia: linkage and non-linkage to the ApoB gene in Caucasian families;Pulai;Am J Med Genet,1998

2. Linkage of a gene for familial hypobetalipoproteinemia to chromosome 3p21.1-22;Yuan;Am J Hum Genet,2000

3. Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia;Musunuru;N Engl J Med,2010

4. Identification of a novel mutation in the ANGPTL3 gene in two families diagnosed of familial hypobetalipoproteinemia without APOB mutation;Martin-Campos;Clin Chim Acta,2012

5. Mutations in the ANGPTL3 gene and familial combined hypolipidemia: a clinical and biochemical characterization;Minicocci;J Clin Endocrinol Metab,2012

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene associations of lipid traits, lipid-lowering drug-target genes and endometriosis;Reproductive BioMedicine Online;2024-07

2. Role of the angiopoietin-like protein family in the progression of NAFLD;Heliyon;2024-04

3. ANGPTL3 is a novel HDL component that regulates HDL function;Journal of Translational Medicine;2024-03-10

4. Therapeutic inhibition of angiopoietin-like protein 3 for hypertriglyceridaemia and residual risk of ASCVD: beginning of the end or end of the beginning?;European Journal of Preventive Cardiology;2024-03-06

5. L’évinacumab : un nouveau médicament dans l’arsenal thérapeutique de l’hypercholestérolémie réfractaire;Archives des Maladies du Coeur et des Vaisseaux - Pratique;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3